[go: up one dir, main page]

FI952250L - 5,6-dihydro-4H-tieno/3,4-c/pyrrolijohdannaiset, niiden valmistus ja terapeuttinen käyttö - Google Patents

5,6-dihydro-4H-tieno/3,4-c/pyrrolijohdannaiset, niiden valmistus ja terapeuttinen käyttö Download PDF

Info

Publication number
FI952250L
FI952250L FI952250A FI952250A FI952250L FI 952250 L FI952250 L FI 952250L FI 952250 A FI952250 A FI 952250A FI 952250 A FI952250 A FI 952250A FI 952250 L FI952250 L FI 952250L
Authority
FI
Finland
Prior art keywords
thieno
dihydro
preparation
therapeutic use
pyrrole derivatives
Prior art date
Application number
FI952250A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952250A0 (fi
Inventor
Zurita Manuel Bedoya
Martin Juan Antonio Diaz
Sol Moreno Gregorio Del
Perez Ulpiano Martin Escudero
Bargueno Maria Dolores Jimenez
Ferrer Magali Romanach
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI952250A0 publication Critical patent/FI952250A0/fi
Publication of FI952250L publication Critical patent/FI952250L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI952250A 1994-05-10 1995-05-09 5,6-dihydro-4H-tieno/3,4-c/pyrrolijohdannaiset, niiden valmistus ja terapeuttinen käyttö FI952250L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405716A FR2719844B1 (fr) 1994-05-10 1994-05-10 Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
FI952250A0 FI952250A0 (fi) 1995-05-09
FI952250L true FI952250L (fi) 1995-11-11

Family

ID=9463059

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952250A FI952250L (fi) 1994-05-10 1995-05-09 5,6-dihydro-4H-tieno/3,4-c/pyrrolijohdannaiset, niiden valmistus ja terapeuttinen käyttö

Country Status (17)

Country Link
EP (1) EP0682028A1 (no)
JP (1) JPH0853457A (no)
KR (1) KR950032205A (no)
CN (1) CN1117970A (no)
AU (1) AU1793395A (no)
CA (1) CA2148880A1 (no)
CZ (1) CZ119695A3 (no)
FI (1) FI952250L (no)
FR (1) FR2719844B1 (no)
HU (1) HUT72667A (no)
IL (1) IL113673A0 (no)
NO (1) NO951812L (no)
NZ (1) NZ272090A (no)
PL (1) PL308516A1 (no)
RU (1) RU95107154A (no)
SK (1) SK59795A3 (no)
ZA (1) ZA953749B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
CA2327543A1 (en) 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
JPH06510760A (ja) * 1991-08-27 1994-12-01 ジ・アップジョン・カンパニー 代謝障害および代謝の治療法
EP0599697A1 (fr) * 1992-11-24 1994-06-01 Synthelabo Dérivés de pyrrole, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
HUT72667A (en) 1996-05-28
JPH0853457A (ja) 1996-02-27
IL113673A0 (en) 1995-08-31
ZA953749B (en) 1996-04-02
EP0682028A1 (fr) 1995-11-15
AU1793395A (en) 1995-11-16
CA2148880A1 (fr) 1995-11-11
NZ272090A (en) 1996-03-26
RU95107154A (ru) 1997-03-20
FI952250A0 (fi) 1995-05-09
PL308516A1 (en) 1995-11-13
NO951812L (no) 1995-11-13
SK59795A3 (en) 1995-12-06
NO951812D0 (no) 1995-05-09
FR2719844B1 (fr) 1996-06-07
FR2719844A1 (fr) 1995-11-17
CN1117970A (zh) 1996-03-06
CZ119695A3 (en) 1995-11-15
KR950032205A (ko) 1995-12-20

Similar Documents

Publication Publication Date Title
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
FI955235L (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
FI943912L (fi) Tienopyrimidiinijohdannaiset, niiden valmistus ja käyttö
FI905770L (fi) Uusia isoindolonijohdannaisia niiden valmistus ja käyttö
FI944600L (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
IL116139A0 (en) Pyrrole derivatives their preparation and use
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
FI950458L (fi) N-(3-aminopropyyli)-N-fenyyli-5,6,7,8-tetrahydronaftalen-2-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
IS1913B (is) Trísýklísk 5,6-díhýdró-9H-pýrazóló[3,4c]-1,2,4-tríazóló[4,3a]pýridín, notkun þeirra og lyfjablanda
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
EE9900218A (et) 1,4-diasabitsüklo[2.2.2]okt-2-üülmetüülbensoaadi derivaadid, nende valmistamine ja kasutamine raviks
DK1000063T3 (da) 4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf
EG21121A (en) 13 Substituted milbemycin derivatives their preparation and use
FI940186A (fi) 9H-imidatso/1,2-a/bentsimidatsoli-3-asetamidijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
FI970750L (fi) Indoli-2,3-dioni-3-oksimijohdannaisia, niiden valmistus ja käyttö
EE9900414A (et) 2,3-dihüdrofuro[3,2-b]püridiini derivaadid, nende valmistamine ja kasutamine raviks
EE9800174A (et) 1,4-dihüdro-1,4-diokso-1H-naftaleeni tritsükliliste derivaatide kasutamine, uued ühendid ja nende kasutamine teraapias
IL107726A0 (en) Pyrrole derivatives their preparation and their therapeutic use
FI952250L (fi) 5,6-dihydro-4H-tieno/3,4-c/pyrrolijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI935888L (fi) 2-amino-6,7-dihydroksi-4-tiaheptaanihappojohdannaiset, niiden valmistus ja käyttö
FI954141L (fi) Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine